🇰🇷 Ridaura in South Korea

Ridaura (AURANOFIN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Ridaura in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in South Korea

Frequently asked questions

Is Ridaura approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Ridaura in South Korea?

Legacy Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.